Toxoplasmosis in Cats: Risks to Humans and Public Health Management

Etiology and Life Cycle

Toxoplasmosis is caused by the obligate intracellular apicomplexan protozoan Toxoplasma gondii. The definitive hosts are members of the family Felidae, within which the parasite completes its sexual cycle and produces oocysts [1, 2]. Domestic cats (Felis catus) and wild felids serve as the primary reservoirs for environmental contamination [3, 4]. The life cycle comprises both sexual reproduction in the feline intestinal epithelium and asexual multiplication in a wide range of intermediate hosts including mammals and birds [1]. Following ingestion of tissue cysts from infected prey or raw meat, bradyzoites are released and invade intestinal epithelial cells, initiating the enteroepithelial cycle [5]. This cycle culminates in the production of unsporulated oocysts that are shed in feces, typically starting 3 to 10 days post infection and continuing for one to three weeks [6, 7]. Each infected cat can shed millions of oocysts, which then sporulate in the environment and become infective to intermediate hosts [8, 9].

The sexual stages of the parasite have been characterized in detail, with the proliferative pre-sexual stages undergoing a specific cell division process that is critical for the production of gametes [1]. MicroRNA expression dynamics within the feline small intestine during infection reveal a complex host-parasite interplay that may influence parasite replication and shedding patterns [5]. Once oocysts are ingested by an intermediate host, they sporulate and release sporozoites that transform into tachyzoites, the rapidly dividing stage responsible for acute infection and dissemination [10, 11].

Epidemiology and Prevalence in Feline Populations

Seroprevalence of T. gondii in domestic cats varies widely based on geographic location, lifestyle, and access to prey. Studies in Hong Kong reported seroprevalences in privately owned cats and community cats of approximately 25% and 40%, respectively, with outdoor access and raw feeding identified as significant risk factors [12]. In Jordan, the first molecular detection of toxoplasmosis in cats found a seroprevalence of 42% and a molecular detection rate of 18% in feces, with stray cats showing higher infection rates than owned cats [7]. In Bangkok, stray cats exhibited a 15% prevalence of T. gondii DNA in fecal samples as determined by PCR [6]. In Brazil, a study of domestic and companion animals in urban informal settlements reported a 60% seroprevalence in cats, with increasing age and free-roaming behavior as predictors of infection [3]. Wild felids in Poland showed a seroprevalence of 49%, confirming that sylvatic cycles maintain the parasite in natural ecosystems [4].

Transmission risk is amplified in environments with high cat densities, poor sanitation, and soil contamination [8]. Veterinary professionals and students are at elevated risk of exposure due to occupational contact with feline feces and contaminated surfaces, as evidenced by seroprevalence studies in Mexico [13].

Clinical Signs and Pathology in Cats

Most feline infections are subclinical. However, clinical disease can manifest in immunocompromised cats or neonates. Ocular toxoplasmosis presents as uveitis, chorioretinitis, and retinal detachment [14]. Neurological signs include ataxia, seizures, tremors, and behavioral changes, which are attributable to the formation of tissue cysts and necrotic foci in the brain [15, 16]. Pulmonary toxoplasmosis manifests as dyspnea and interstitial pneumonia, while hepatic involvement leads to icterus and elevation of liver enzymes.

Systemic infection in cats can result in fever, lethargy, anorexia, and lymphadenopathy [16]. The MIC17A antigen has been identified as a potential marker for both enteroepithelial and chronic stage infection, offering a serological target for detecting active and latent infections in cats [16]. In cases of vertical transmission, transplacental infection may lead to abortion, stillbirth, or neonatal death [17, 18]. T. gondii has been detected in reproductive tissues of companion animals enrolled in municipal neutering programs, suggesting a risk for vertical transmission even in subclinically infected queens [17].

Pathology and Host Cell Interactions

The pathophysiology of toxoplasmosis is driven by the parasite's ability to invade and replicate within nucleated cells. Tachyzoites utilize gliding motility and secretion of microneme and rhoptry proteins to penetrate host cell membranes and form a parasitophorous vacuole [10]. Inside this vacuole, the parasite evades lysosomal fusion and scavenges nutrients from the host cytoplasm. The resulting cell lysis causes focal necrosis and an intense inflammatory response characterized by mononuclear cell infiltration [19, 20].

In the feline intestine, the sexual cycle leads to disruption of epithelial integrity and microvillous atrophy, which can cause diarrhea and malabsorption [5]. In the brain, cyst formation is associated with altered dopamine metabolism and behavioral changes, a phenomenon that has been linked to increased risk-taking behavior in intermediate hosts [15]. In humans, cerebral toxoplasmosis is a well recognized complication in transplant recipients and immunocompromised patients [19]. The parasite's tropism for neural and muscular tissue is mediated by surface antigens such as SAG1, which facilitate host cell attachment and invasion [21].

Diagnostics

Ante mortem diagnosis of feline toxoplasmosis relies on a combination of serological, molecular, and fecal examination techniques. Detection of anti-T. gondii immunoglobulin M (IgM) and immunoglobulin G (IgG) antibodies is performed using commercial enzyme-linked immunosorbent assays (ELISAs) or indirect immunofluorescence assays. A four fold rise in IgG titer or positive IgM serology indicates recent infection [16, 7]. Field deployable immunochromatographic strip tests based on double-antigen sandwich colloidal gold technology have been developed for multi-species serosurveillance, including cats [22, 21]. These assays utilize recombinant SAG1 as the capture antigen and offer rapid, point-of-care detection of antibodies.

Molecular diagnostics include conventional PCR and quantitative real-time PCR targeting the 529 bp repetitive element or the B1 gene of T. gondii [6, 23]. An antisense PCR assay has been developed specifically for domestic cats, demonstrating increased sensitivity over conventional PCR for detecting the parasite in fecal samples [23]. PCR on fecal samples is useful for identifying oocyst shedding, though intermittent shedding limits sensitivity [6]. Histopathological examination of tissue biopsies using immunohistochemistry can identify tachyzoites and tissue cysts in the brain, lung, liver, and placenta [18]. In cases of abortion or stillbirth, molecular detection of T. gondii DNA in fetal tissues such as myocardium provides definitive diagnosis [18].

The following table summarizes the primary diagnostic methods and their applications:

Treatment and Management in Cats

Treatment is indicated in cats with clinical toxoplasmosis. The standard therapeutic regimen includes clindamycin hydrochloride administered orally or parenterally at a dose of 10 to 12 mg/kg every 12 hours for 14 to 28 days. Alternative antiprotozoal agents include trimethoprim-sulfonamide combinations and pyrimethamine. Folinic acid supplementation is recommended to mitigate bone marrow suppression associated with pyrimethamine. Supportive care includes fluid therapy, nutritional support, and anti-inflammatory doses of corticosteroids in cases of ocular or central nervous system inflammation.

There is currently no approved vaccine for feline toxoplasmosis, though gene-edited live-attenuated vaccines are under development and show promise in reducing oocyst shedding [10, 24]. These candidate vaccines target key parasite genes involved in replication and differentiation, with the aim of inducing sterile immunity. Antigen discovery efforts have informed mRNA vaccine strategies that could be applied within a One Health framework [24].

Public Health Management and Risks to Humans

Cat Toxoplasmosis Baby

The risk of congenital toxoplasmosis following primary maternal infection during pregnancy is a central public health concern. When a pregnant woman becomes infected for the first time, tachyzoites can cross the placenta and infect the fetus, leading to chorioretinitis, hydrocephalus, intracranial calcifications, and developmental delay in the neonate [25, 26, 27]. Studies in Turkey and Côte d'Ivoire have highlighted the association between seronegativity in pregnant women and lack of knowledge about toxoplasmosis prevention [25, 26]. Advice to seronegative pregnant women who own cats includes avoiding litter box cleaning, using gloves for gardening, and thoroughly washing vegetables to prevent ingestion of sporulated oocysts [27]. The term "cat toxoplasmosis baby" encapsulates this specific risk pathway: exposure of a seronegative pregnant woman to oocysts shed by an infected cat [25].

Ocular Toxoplasmosis

Ocular toxoplasmosis in humans occurs as a result of congenital infection or postnatally acquired infection. Retinochoroiditis is the most common manifestation, characterized by necrotizing granulomatous inflammation of the retina and choroid [14]. Recurrent episodes are common due to reactivation of dormant tissue cysts. Studies in quilombola communities in Brazil have demonstrated a high burden of ocular toxoplasmosis associated with poor sanitation and close contact with cats [28].

Neurological and Behavioral Effects

Chronic T. gondii infection in humans has been associated with altered behavior and psychiatric conditions. A population-based cohort study found that childhood T. gondii seropositivity was associated with psychotic experiences and reduced grey matter volume in specific brain regions [20]. The parasite manipulates host behavior by inducing changes in neurotransmitter levels, a phenomenon observed across multiple host species [15]. These findings reinforce the importance of preventing environmental contamination with feline oocysts.

High-Risk Populations

Immunocompromised individuals, including organ transplant recipients and those with HIV/AIDS, are at risk for severe toxoplasmosis, particularly cerebral toxoplasmosis [19]. Patients with sickle cell disease have a higher seroprevalence compared to the general population, possibly due to transfusion-related transmission [11]. Veterinary professionals and students are at occupational risk because of frequent exposure to feline feces [13]. Seroprevalence studies of pregnant women have revealed significant knowledge gaps regarding transmission routes, necessitating targeted education campaigns [26, 29].

Control Strategies

Control of toxoplasmosis requires an integrated One Health approach. Key strategies include reducing the outdoor roaming of cats, providing commercial cooked or canned food to prevent ingestion of tissue cysts from prey, daily cleaning of litter boxes to remove oocysts before sporulation, and proper disposal of cat feces in sealed bags [8, 26, 27]. Environmental interventions such as covering sandboxes, preventing cat access to vegetable gardens, and reducing feral cat populations contribute to lowering oocyst loads in the environment [8, 6]. Education of pet owners, pregnant women, and veterinary professionals about the risks associated with "cat toxoplasmosis baby" transmission is a core component of public health management [25, 26, 27].

The following Mermaid diagram illustrates the public health decision tree for managing feline toxoplasmosis in a household with a pregnant resident:

flowchart TD
    A[Pregnant woman lives with cat], > B{Serological status of woman}
    B, >|Immune IgG+| C[No special precautions needed]
    B, >|Seronegative IgG-/IgM-| D[Risk assessment]
    D, > E{Testing of cat}
    E, >|Cat seropositive| F[Identify oocyst shedding period]
    F, > G[Implement strict hygiene protocols]
    G, > H[Woman avoids litter box cleaning]
    G, > I[Daily litter box change with gloves]
    G, > J[Cat kept indoors, no raw meat]
    E, >|Cat seronegative| K[Maintain preventive measures]
    K, > L[Keep cat indoors]
    K, > M[Feed cooked or commercial diet]
    K, > N[Annual serological monitoring of cat]
    D, > O[Education on environmental precautions]
    O, > P[Avoid gardening without gloves]
    O, > Q[Wash all produce thoroughly]
    O, > R[Cover children's sandboxes]

Conclusion

Toxoplasma gondii infection in cats represents a significant zoonotic risk that demands a structured public health management approach. The feline definitive host is central to the parasite's transmission cycle, and environmental contamination with oocysts is the primary route of human exposure. Diagnostic advancements including antisense PCR and multi-species serological strips have improved detection capabilities [22, 21, 23]. Gene-edited vaccines are on the horizon and may eventually reduce cat toxoplasmosis baby risk by preventing oocyst shedding [10, 24]. Public health interventions must target education, sanitation, and responsible pet ownership to mitigate the impact of this widespread parasite.

References

[1] Sena F, Hakimi M-A, Francia ME. Proliferating toward sex: characterization of cell division of Toxoplasma gondii's pre-sexual stages. mBio. 2026. https://pubmed.ncbi.nlm.nih.gov/42153709/

[2] Spada E, Tattarletti G, Proverbio D, et al. The AB Blood Group System Phenotype Does Not Play a Role in Toxoplasma gondii Infection in Cats. Pathogens. 2025. https://pubmed.ncbi.nlm.nih.gov/41471183/

[3] Bazan L, Argibay HD, Borges-Silva W, et al. Seroprevalence and risk factors for Toxoplasma gondii infection in wild, domestic and companion animals in urban informal settlements from Salvador, Brazil. PLoS Negl Trop Dis. 2025. https://pubmed.ncbi.nlm.nih.gov/41401226/

[4] Didkowska A, Kołodziej-Sobocińska M, Matusik K, et al. Toxoplasma gondii in wild felides in Poland. BMC Vet Res. 2025. https://pubmed.ncbi.nlm.nih.gov/41387866/ *** Disclaimer: This article is for educational and informational purposes only. It is not intended to substitute for professional veterinary advice, diagnosis, treatment, or regulatory guidance. Always consult a licensed veterinarian or qualified specialist regarding animal health, disease diagnosis, and therapeutic decisions.

[5] Zhai B, Bao B, Xie SC, et al. Dynamic landscape of microRNA expression in the feline small intestine during Toxoplasma gondii infection. Parasit Vectors. 2026. https://pubmed.ncbi.nlm.nih.gov/41965856/

[6] Kengradomkij C, Chimnoi W, Kamyingkird K, et al. PCR detection of Toxoplasma gondii DNA in fecal samples from stray cats in Bangkok Metropolitan, Thailand. Food Waterborne Parasitol. 2026. https://pubmed.ncbi.nlm.nih.gov/42094705/

[7] Alkhatatbeh SK, Lafi SQ, Hammad HB, et al. The first seroprevalence and molecular detection of toxoplasmosis infecting cats in Jordan with associated risk factors. Vet Parasitol Reg Stud Reports. 2026. https://pubmed.ncbi.nlm.nih.gov/41741047/

[8] Eyre MT, Wang JY, Carneiro IO, et al. Social marginalisation, environmental degradation and Toxoplasma gondii exposure in urban informal settlements in Brazil. PLoS Negl Trop Dis. 2026. https://pubmed.ncbi.nlm.nih.gov/42330015/

[9] Biswas PK, Aryal D, Tarak AN, et al. Genotype distribution and risk factors of Toxoplasma gondii infection in animals of Trishal, Bangladesh. PLoS One. 2026. https://pubmed.ncbi.nlm.nih.gov/41528989/

[10] Sang X, Zhang H, Zhang Y, et al. Gene-edited live-attenuated vaccines against Toxoplasma gondii: recent advances and future frontiers. Parasit Vectors. 2026. https://pubmed.ncbi.nlm.nih.gov/42252477/

[11] Orish VN, Tetteh RE, Adzah D, et al. Toxoplasma gondii seropositivity among patients with sickle cell disease: Prevalence and association with blood transfusion history. PLoS One. 2026. https://pubmed.ncbi.nlm.nih.gov/41931585/

[12] Elsohaby I, Zubair M, Baqar Z, et al. Seroprevalence of Toxoplasma gondii and associated demographic factors in privately-owned dogs, cats, and community cats in Hong Kong. BMC Vet Res. 2026. https://pubmed.ncbi.nlm.nih.gov/42135800/

[13] de Velasco-Reyes I, Torres-García SE, Hernández-Rangel JJ, et al. Seroprevalence of Toxoplasma gondii Infection in Veterinary Medicine Professionals and Students in Aguascalientes, Mexico. Epidemiologia (Basel). 2026. https://pubmed.ncbi.nlm.nih.gov/42201205/

[14] Askaryanzardak A, Kakkassery V, Tartaglione Gracia GP, et al. Ocular toxoplasmosis in adults: Refresher course. Ophthalmologie. 2026. https://pubmed.ncbi.nlm.nih.gov/41603939/

[15] Loeb J. Thrill seekers: how parasites change host behaviour. Vet Rec. 2026. https://pubmed.ncbi.nlm.nih.gov/41481062/

[16] Günay-Esiyok Ö, Koçkaya ES, Yılmaz R, et al. The Potential of MIC17A both as an Entero-epithelial and Chronic Stage Marker for Detection of Feline Toxoplasmosis. Curr Microbiol. 2026. https://pubmed.ncbi.nlm.nih.gov/41874672/

[17] Murata FHA, Barboza JP, de Souza CAG, et al. Investigation of Toxoplasma gondii in reproductive tissues of companion animals from a municipal neutering program. Vet Parasitol Reg Stud Reports. 2026. https://pubmed.ncbi.nlm.nih.gov/41651631/

[18] Ait Issad N, Mohamed Cherif A, Mebkhout F, et al. First report of molecular and histopathological detection of Toxoplasma gondii in aborted fetal goat myocardium in Algeria with associated risk factors. Parasitol Int. 2026. https://pubmed.ncbi.nlm.nih.gov/41864556/

[19] Mihaljević D, Sitaš Z, Hanulak J, et al. Cerebral Toxoplasmosis in a Renal Transplant Recipient-A Rare Complication. Life (Basel). 2026. https://pubmed.ncbi.nlm.nih.gov/41900989/

[20] Jesuthasan J, Merritt K, Solmi F, et al. The association between childhood Toxoplasma gondii, psychotic experiences and grey matter volume: A population-based cohort study. Schizophr Res. 2026. https://pubmed.ncbi.nlm.nih.gov/41643571/

[21] Chen XX, Sun H, Liang Y, et al. Development of a SAG1-based colloidal gold immunochromatographic strip for rapid serological detection of swine Toxoplasma gondii. Parasit Vectors. 2026. https://pubmed.ncbi.nlm.nih.gov/42169035/

[22] Mu X, Chen C, Pu X, et al. Development and Field Validation of a Double-Antigen Sandwich Colloidal Gold Immunochromatographic Strip for Detection of Toxoplasma gondii Antibodies in Multiple Host Species. Transbound Emerg Dis. 2026. https://pubmed.ncbi.nlm.nih.gov/42253330/

[23] Li YY, Bai SY, Yu HQ, et al. Development and evaluation of an antisense PCR assay for Toxoplasma gondii detection in domestic cats. Vet Parasitol. 2026. https://pubmed.ncbi.nlm.nih.gov/41724116/

[24] Qadeer A, Tharwat M, Khan MZ, et al. Advances and Translational Challenges in Toxoplasma gondii Vaccine Development: From Antigen Discovery to mRNA and One Health Strategies. Vet Sci. 2026. https://pubmed.ncbi.nlm.nih.gov/42188907/

[25] Karacali B, Mor N. Investigation of anti-Toxoplasma gondii antibody seropositivity and possible risk factors in women with abortion or stillbirth history in Kars, Turkey. Afr J Reprod Health. 2026. https://pubmed.ncbi.nlm.nih.gov/42202767/

[26] Henriette BA, Jémima EK, Jean-Sébastien MA, et al. First report of knowledge and practices towards toxoplasmosis among pregnant women in primary care in Abidjan, Côte d'Ivoire. Trop Parasitol. 2026. https://pubmed.ncbi.nlm.nih.gov/42199683/

[27] Gharbi M, Yera H, Dupouy-Camet J. The cat, the women and the toxoplasma: What advice should be given to a pregnant woman who is seronegative for toxoplasmosis and owns a cat? Gynecol Obstet Fertil Senol. 2026. https://pubmed.ncbi.nlm.nih.gov/41628830/

[28] Filho SCC, Moron SE, Ferreira RG, et al. Risk Factors and Ocular Health Associated with Toxoplasmosis in Quilombola Communities. Microorganisms. 2026. https://pubmed.ncbi.nlm.nih.gov/41597614/

[29] Chalabi KN, Jabar Bakr E. Toxoplasmosis - knowledge among university students in Erbil, Iraq: a cross-sectional study. Int J Environ Health Res. 2026. https://pubmed.ncbi.nlm.nih.gov/41873025/

[30] Pinto GOA, Silva RAD, Oliveira PRF, et al. Molecular detection of Toxoplasma gondii in an aborted equine fetus and serological evidence of infection in mares enrolled in embryo transfer programs in Brazil. J Equine Vet Sci. 2026. https://pubmed.ncbi.nlm.nih.gov/42252005/

[31] Aziz KJ, Mikaeelb FB, Nasrullah OJ, et al. Seroepidemiological investigation of Toxoplasma gondi and Neospora caninum in local Deers in Erbil, Iraq. Vet Parasitol Reg Stud Reports. 2026. https://pubmed.ncbi.nlm.nih.gov/42034957/

[32] Muhammad AS, Kudi AC, Mohammed A, et al. Public health significance of prevalence and risk factors associated with Toxoplasma gondii infection in goats sampled from two quarantine facilities and an institutional farm in Maiduguri metropolis, Borno state, Nigeria. Sci Rep. 2026. https://pubmed.ncbi.nlm.nih.gov/42020619/

[33] Artiaga-Silva GL, de Lima Ruy Dias ÁF, Carvalho MR, et al. High Seroprevalence Rates of Toxoplasma gondii and Neospora caninum in Dogs in the Pantanal Region of Mato Grosso, Brazil. Acta Parasitol. 2026. https://pubmed.ncbi.nlm.nih.gov/41843222/

[34] Hanedan B, Taş BZ, Yıldırım E, et al. Investigation of Toxoplasma gondii seroprevalence and associated risk factors in dairy cattle in the Eastern Anatolia region of Türkiye. Vet Parasitol Reg Stud Reports. 2026. https://pubmed.ncbi.nlm.nih.gov/41819961/

[35] Marín-García PJ, Ballesteros-García O, Martínez-Sáez L, et al. Low seroprevalence of Toxoplasma gondii in pig farms (Sus scrofa domesticus) of eastern Spain in intensive farms with control of animal entry. Vet Parasitol Reg Stud Reports. 2026. https://pubmed.ncbi.nlm.nih.gov/41741032/